SARI, A. Et Al. 2017. Rituximab Experience in Patients With Long-standing Systemic Sclerosis-Associated Interstitial Lung Disease: A Series of 14 Patients. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.23, no.8 , 411-415.

SARI, A., Guven, D., ARMAĞAN, B., ERDEN, A., KALYONCU, U., KARADAĞ, Ö., ... APRAŞ BİLGEN, Ş. Ş.(2017). Rituximab Experience in Patients With Long-standing Systemic Sclerosis-Associated Interstitial Lung Disease: A Series of 14 Patients. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.23, no.8, 411-415.

SARI, ALPER Et Al. "Rituximab Experience in Patients With Long-standing Systemic Sclerosis-Associated Interstitial Lung Disease: A Series of 14 Patients," JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.23, no.8, 411-415, 2017

SARI, ALPER Et Al. "Rituximab Experience in Patients With Long-standing Systemic Sclerosis-Associated Interstitial Lung Disease: A Series of 14 Patients." JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.23, no.8, pp.411-415, 2017

SARI, A. Et Al. (2017) . "Rituximab Experience in Patients With Long-standing Systemic Sclerosis-Associated Interstitial Lung Disease: A Series of 14 Patients." JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , vol.23, no.8, pp.411-415.

@article{article, author={ALPER SARI Et Al. }, title={Rituximab Experience in Patients With Long-standing Systemic Sclerosis-Associated Interstitial Lung Disease: A Series of 14 Patients}, journal={JCR-JOURNAL OF CLINICAL RHEUMATOLOGY}, year=2017, pages={411-415} }